Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

FDA Drug Recalls

74 recalls, newest first

Class II · Moderate risk

suntegrity

CGMP Deviations

Ongoing cGMP deviation Synchronicity Spa INC, Dba Sunte D-0589-2024
Class II · Moderate risk

minolira (minocycline hydrochloride)

CGMP Deviation: Discontinuation of the Quality program by manufacturer that would assure product meet the identity, strength, quality, and purity characteristics that they are purported or represented to possess.

Terminated cGMP deviation EPI Health, LLC NDC 71403-102-30 D-0475-2024
Class II · Moderate risk

minolira (minocycline hydrochloride)

CGMP Deviation: Discontinuation of the Quality program by manufacturer that would assure product meet the identity, strength, quality, and purity characteristics that they are purported or represented to possess.

Terminated cGMP deviation EPI Health, LLC NDC 71403-101-30 D-0474-2024
Class II · Moderate risk

Cloderm (clocortolone pivalate)

CGMP Deviation: Discontinuation of the Quality program by manufacturer that would assure product meet the identity, strength, quality, and purity characteristics that they are purported or represented to possess.

Terminated cGMP deviation EPI Health, LLC NDC 71403-804-90 D-0473-2024
Class II · Moderate risk

Gordofilm Wart Remover

cGMP Deviations

Completed cGMP deviation Dercher Enterprises, Inc., DBA Gordon Laboratories NDC 10481-3009-01 D-0495-2024
Class II · Moderate risk

Eyesaline

CGMP Deviations

Terminated cGMP deviation Honeywell INC D-0461-2024
Class II · Moderate risk

PROBLEND Hand Sanitizer

CGMP Deviations: deficiencies were identified during an FDA inspection of Seatex's manufacturing facility.

Terminated cGMP deviation Seatex LLC D-0360-2024
Class II · Moderate risk

7 Eleven Hand Sanitizer Gel

CGMP Deviations: deficiencies were identified during an FDA inspection of Seatex's manufacturing facility.

Terminated cGMP deviation Seatex LLC D-0359-2024

Recalls by year